FB23‐2 exerts remarkable inhibition of leukemic proliferation in AML cells and mouse models.[32] Herein, we demonstrated that FB23‐2 effectively suppressed tumor progression in T‐ALL cells and Notch1‐induced T‐ALL mice by elevating m6A modification. The gene discussed is NOTCH1; the disease is acute myeloid leukemia.